• The most common manifestation of hereditary hemorrhagic telangiectasia (HH) is recurrent epistaxis. Numerous treatments have been used over the years, none proving entirely satisfactory. We have applied a new surgical treatment in seven selected cases of HHT with severe, life-threatening epistaxis. It consists of a near-total excision of the diseased nasal mucosa and its replacement by different skin flaps or a myocutaneous flap. This procedure has been performed since 1981. We stress the reliability and versatility of using the forehead myocutaneous island flap. Our original technique is described, follow-up of the patients is reported, and the criteria for selection of treatment are discussed.
(Arch Otolaryngol Head Neck Surg 1987;113:754-757)
Zohar Y, Sadov R, Shvili Y, Talmi Y, Laurian N. Surgical Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia. Arch Otolaryngol Head Neck Surg. 1987;113(7):754–757. doi:10.1001/archotol.1987.01860070068018
Otolaryngology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.